Results 241 to 250 of about 2,834,658 (290)
Some of the next articles are maybe not open access.
Multiple Sclerosis Journal, 1996
As a result of recent therapeutic trials, recombinant Interferon beta (r/FNβ)-1b and-1a as well as Copolymer 1 (COP 1) and to some extent unspecific immunosuppressants have been accepted as partially efficient treatments of relapsing-remitting MS. In view of partially effective single treatments, the question arises if combination of two or even more ...
openaire +3 more sources
As a result of recent therapeutic trials, recombinant Interferon beta (r/FNβ)-1b and-1a as well as Copolymer 1 (COP 1) and to some extent unspecific immunosuppressants have been accepted as partially efficient treatments of relapsing-remitting MS. In view of partially effective single treatments, the question arises if combination of two or even more ...
openaire +3 more sources
2013
Antimicrobial combination therapy has a long history. The potential for synergy between two antimicrobial agents has been sought using in vitro techniques such as disk approximation, checkerboard titration, in vitro killing experiments with fixed drug concentrations, through the use of in vitro pharmacodynamic models, through animal models, and through
openaire +1 more source
Antimicrobial combination therapy has a long history. The potential for synergy between two antimicrobial agents has been sought using in vitro techniques such as disk approximation, checkerboard titration, in vitro killing experiments with fixed drug concentrations, through the use of in vitro pharmacodynamic models, through animal models, and through
openaire +1 more source
Rationale for drug combinations
European Journal of Cancer, 2003No reader of this journal needs to be reminded that real progress in the treatment of solid tumours is hard to achieve. The explosion of scientific knowledge about the metabolism of tumours and the genetic influences that promote or restrict growth will it is hoped lead to the more rationale design of therapeutics, which in future will be more ...
openaire +2 more sources
Combination drug therapy for combined hyperlipidemia
Current Cardiology Reports, 1999Combination therapy for hyperlipidemia, especially combined hyperlipidemia, may have advantages over single drug therapy, affording better improvement in lipoprotein risk factors and possibly better prevention of atherothrombotic events. Although preliminary experience has been gained using treatment combinations of niacin with statins, and fibrates ...
openaire +2 more sources
Clinical Utility of Solid Tumor Epigenetics
Medical Epigenetics, 2021Sevin Turcan, Julian Taranda
exaly
Antibody–Drug Conjugates: Smart Chemotherapy Delivery Across Tumor Histologies
Ca-A Cancer Journal for Clinicians, 2022Shanu Modi +2 more
exaly
Combination cardiovascular drugs
Nursing, 2017Kavitha S, Dalal, Mary Barna, Bridgeman
openaire +2 more sources